IMBA

A 2024 Cyclist Buyer's Guide to America's Best Bicycle Insurance

Retrieved on: 
Wednesday, January 3, 2024
International, Bicycle industry, Policy, Travel, The Better Way, Theft, Classification, League, Price point, Accident, Insurance, USA Cycling, Organization, IMBA, Road

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- BikeInsure, an insurtech company specializing in bicycle insurance for cyclists in the United States, has released a 2024 Cyclist Buyer's Guide to America's Best Bike Insurance. Today's cyclists need separate bike insurance to protect their new or used bicycles and eBikes from riding, transit, or theft risks. The Bicycle Insurance Buyer's Guide will define 'The Better Way' for cyclists in the United States to protect their bikes and eBikes, which includes all 3-Class electric bicycle standards, and making a claim with the separate bike insurance, like BikeInsure, won't affect other insurance policies.

Key Points: 
  • A separate bicycle insurance policy is the best way to insure your bicycle or eBike from risks of riding, transit, or theft.
  • GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- BikeInsure, an insurtech company specializing in bicycle insurance for cyclists in the United States, has released a 2024 Cyclist Buyer's Guide to America's Best Bike Insurance.
  • Today's cyclists need separate bike insurance to protect their new or used bicycles and eBikes from riding, transit, or theft risks.
  • Unlike homeowners' insurance policies considered catastrophic home loss protection and do not offer adequate bicycle coverage and insurance policies that exclude electric bikes due to their classification as motorized vehicles, America's Best Bicycle Insurance provides comprehensive coverage for both.

Fudan University School of Management's Three Programs Ranked among the Top 30 Globally

Retrieved on: 
Monday, October 23, 2023
Financial Times, Yangtze Delta, Education, Fudan University, Kellogg-HKUST Executive MBA Program, Research, Guanghua School of Management, Multimedia, IMBA, Growth, School, Curriculum, BI Norwegian Business School, Student, EMBA, Ecosystem, Management, University, Entrepreneurship

The Fudan EMBA Program finished 8th globally, retaining the top position among Chinese-taught EMBA programs.

Key Points: 
  • The Fudan EMBA Program finished 8th globally, retaining the top position among Chinese-taught EMBA programs.
  • The University of Hong Kong-Fudan University IMBA Programme was ranked 24th worldwide with the highest salary growth rate globally.
  • The BI Norwegian Business School-Fudan University MBA Program was placed 29th globally, landing first in International Faculty Rank among Global Part-time MBA Programs.
  • Fudan University EMBA's notable ascent in the global rankings is a testament to the program's innovative educational philosophy and forward-thinking teaching methodologies.

International Business School Suzhou at XJTLU celebrates 10 years with alumni event

Retrieved on: 
Monday, September 18, 2023
AACSB, Welfare, Generation Z, International, Workplace, Generation, Triple Crown, IBSS, Mentorship, AstraZeneca, Accounting, IMBA, Business administration, Student, Entrepreneurship, International business, Xi'an Jiaotong-Liverpool University, EQUIS, AMBA, Management

SUZHOU, China, Sept. 18, 2023 /PRNewswire/ -- International Business School Suzhou (IBSS) at Xi'an Jiaotong-Liverpool University kicked off its 10th anniversary year with an alumni reunion on 9 September.

Key Points: 
  • SUZHOU, China, Sept. 18, 2023 /PRNewswire/ -- International Business School Suzhou (IBSS) at Xi'an Jiaotong-Liverpool University kicked off its 10th anniversary year with an alumni reunion on 9 September.
  • An award ceremony recognised three alumni who have made exceptional contributions to business, society and academia:
    Shaanxi province entrepreneur and investor Boyue Xing, who earned a BA in Business Administration in 2018, was named 2023 IBSS Alumni of the Year for his business leadership and achievements.
  • HR leader Sirena Bai, who earned an International MBA in 2021, received the IBSS Alumni Outstanding Contribution Award for promoting collaborations between IBSS and AstraZeneca.
  • "Having an entrepreneurial spirit is vital in business, and investing in social welfare can yield unexpected benefits for the company."

Trailblazing Change: Central Oregon Trail Alliance Enhances Bend's Mountain Bike Trails for Adaptive Riders

Retrieved on: 
Thursday, April 27, 2023
Volunteering, Built environment, Athlete, IMBA, Recreation, Universal design, COTA, Education, International Mountain Bicycling Association, Map, International, OAS, Road, Central Oregon

BEND, Ore., April 27, 2023 /PRNewswire/ -- Central Oregon Trail Alliance (COTA) announces a project to increase mountain bike trail accessibility for riders of adaptive mountain bikes in Bend, Oregon.

Key Points: 
  • BEND, Ore., April 27, 2023 /PRNewswire/ -- Central Oregon Trail Alliance (COTA) announces a project to increase mountain bike trail accessibility for riders of adaptive mountain bikes in Bend, Oregon.
  • In collaboration with key leaders in accessible recreation, COTA aims to promote accessible riding opportunities in Central Oregon.
  • From May 1-14, 2023, a team of adaptive mountain bikers will assess 100 miles of trails near Bend, including the trail experience, trailhead facilities, and accessibility barriers.
  • "I'm excited to put Central Oregon on the map for the adaptive cycling community," said Abbie Wilkiemeyer, COTA's volunteer project manager.

Three Fudan Programs make the list of Financial Times' Top 20 Global EMBA Programs

Retrieved on: 
Monday, October 24, 2022
EMBA, STI, Growth, BI Norwegian Business School, Education, Fudan University, Entrepreneurship, Zhejiang Sci-Tech University, Guanghua School of Management, Kellogg School of Management, MBA, Program, Research, Kellogg-HKUST Executive MBA Program, Multimedia, FT, History, University, Student, Economic development, IMBA, Northwestern University, Ecosystem, Creativity, School, Leadership, Management

SHANGHAI, Oct. 24, 2022 /PRNewswire/ -- In the latest FT global EMBA ranking published on October 17, 2022, four programs of the School of Management, Fudan University (FDSM) were ranked among the global top 50 for the third consecutive year. FDSM was also the only business school on the list with three programs placing among the top 20. The School has received international accolades for its excellent performance and leadership role in Chinese EMBA education.

Key Points: 
  • FDSM was also the only business school on the list with three programs placing among the top 20.
  • This year, four FDSM EMBA programs were named in the rankings: the Fudan EMBA Program, the Washington University-Fudan University EMBA Program, the University of Hong Kong-Fudan University IMBA Programme and the BI Norwegian Business School-Fudan University MBA Program.
  • The results showed that the Fudan EMBA Program finished 12th globally, ranking No.
  • The Washington University-Fudan University EMBA Program came in 9th worldwide, as well as No.1 in Research Rank for three consecutive years in Asia.

EQS-News: HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases

Retrieved on: 
Wednesday, October 5, 2022
Molecular Devices, EQS, Time, Drug, Cardioid, Drug development, 3D, Degenerative disease, Research, Regeneration, Vienna, Institute, Technology, AWS, Company, Drug discovery, Austrian Research Promotion Agency, IMBA, AG, Heart failure, Boehringer Ingelheim, CEO, FFG, Vienna Biocenter, Safety, News, Clinical trial, Cell, Institute of Molecular Biotechnology, Seed (programming), Solution, Myocardial infarction, Security (finance), Pharmaceutical industry

The collaboration aims to accelerate development of new therapy options and achieve better outcomes for people with heart diseases.

Key Points: 
  • The collaboration aims to accelerate development of new therapy options and achieve better outcomes for people with heart diseases.
  • Boehringer Ingelheim will work with the scientists from HeartBeat.bio to further advance the companys platform using selected reference compounds from Boehringer Ingelheims research and development programs.
  • [1] Existing cardiac safety screening models, such as cardiomyocytes, are limited in predictability as they are not able to sufficiently recapitulate human heart physiology.
  • HeartBeat.bios heart organoids are stem-cell derived 3D cell culture systems, which mimic the human heart physiology in a totally new way.

IQAX wins Smart Supply Chain and Logistics Gold Chain Prize

Retrieved on: 
Wednesday, September 21, 2022
LCL, Machine learning, OOCL, SZ, Orient Overseas (International) Limited, Organization, Excellent, Information technology, Gold, Industry, Environment, Technology, Solution, Artificial intelligence, Ecosystem, IMBA, Association, Ferry, AI, Blockchain, APAC, IOT, Medical device, Warehouse, Cargo

HONG KONG, Sept. 21, 2022 /PRNewswire/ -- IQAX Limited, a leading innovator of digital solutions for the logistics industry, is proud to announce that it has won the Gold Chain Prize for Excellent Supply Chain Innovation at the Smart Supply Chain and Logistics Innovation Summit & Expo (APAC) (SSCL), held on 20 to 21 September 2022.

Key Points: 
  • HONG KONG, Sept. 21, 2022 /PRNewswire/ -- IQAX Limited, a leading innovator of digital solutions for the logistics industry, is proud to announce that it has won the Gold Chain Prize for Excellent Supply Chain Innovation at the Smart Supply Chain and Logistics Innovation Summit & Expo (APAC) (SSCL), held on 20 to 21 September 2022.
  • IQAX leverages innovative technologies to develop powerful solutions for shipping and logistics in pursuit of a harmonized global trade environment," said IQAX CEO Romney Wong.
  • "We are honored to receive the prize for Excellent supply chain innovation, a prize that highlights the many benefits that IQAX technology-driven products bring to shipping and logistics."
  • The SSCL conference, the fifth this year, is a B2B platform to exchange information and facilitate business cooperation in the supply chain and logistics sectors.

DGAP-News: HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

Retrieved on: 
Monday, September 12, 2022
Institute, Software, Degenerative disease, Therapy, Time, Vienna, 3D, Efficiency, Review, Risk, AG, Drug, LLC, Company, Vienna Biocenter, Partnership, Regeneration, Patient, Clinical trial, CEO, Technology, Biology, Â, Molecular Devices, Solution, CA, Molecule, IMBA, SAN, Myocardial infarction, Research, Silicon, Cardiotoxicity, Drug discovery, Failure, Death, Institute of Molecular Biotechnology, Pharmaceutical industry, Cardioid

The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices Organoid Innovation Center solutions available today.

Key Points: 
  • The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices Organoid Innovation Center solutions available today.
  • The combination of HeartBeat.bios proprietary Cardioid technology and Molecular Devices automated 3D cell culture and image analysis solutions, defines a powerful and compelling partnership.
  • To learn more about how HeartBeat.bio and Molecular Devices technologies are helping advance drug discovery, listen to this recorded panel discussion hosted by Drug Target Review.
  • HeartBeat.bio AG is dedicated to developing the first high-throughput human organoid screening platform for cardiac drug discovery.

Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

Retrieved on: 
Monday, September 12, 2022
Institute, Software, Degenerative disease, Therapy, Time, Vienna, 3D, Efficiency, Review, Risk, AG, Drug, LLC, Molecular Devices, Company, Vienna Biocenter, Partnership, Heart failure, Regeneration, Clinical trial, CEO, Technology, Biology, Solution, IMBA, SAN, Myocardial infarction, Research, Silicon, Cardiotoxicity, Drug discovery, Failure, Death, Institute of Molecular Biotechnology, Pharmaceutical industry, Medical device, Cardioid

SAN JOSE, Calif., and VIENNA, Sept. 12, 2022 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, have entered into a co-development agreement. With cardiovascular diseases the leading cause of death worldwide—claiming 34 lives every minute—and cardiotoxicity a leading cause of drug withdrawals, this collaboration will provide automated solutions to better model disease physiology, discover novel drug targets, and test cardiac toxicity using 3D cell cultures that more accurately represent human biology as compared to traditional animal models. The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices' Organoid Innovation Center solutions available today.

Key Points: 
  • , a leading provider of high-performance life science solutions, and HeartBeat.bio AG , a biotech company developing cardiac organoids (Cardioids) for drug discovery, have entered into a co-development agreement.
  • The commercialized offering will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery, and will be compatible with Molecular Devices' Organoid Innovation Center solutions available today.
  • To learn more about how HeartBeat.bio and Molecular Devices technologies are helping advance drug discovery, listen to this recorded panel discussion hosted by Drug Target Review.
  • HeartBeat.bio AG is dedicated to developing the first high-throughput human organoid screening platform for cardiac drug discovery.

Kawaiiverse Hackathon 2022: Building the Kawaiiverse gaming ecosystem

Retrieved on: 
Wednesday, July 13, 2022
Metaverse, Sale, Anime and manga, Multimedia, EVM, Kawaii, IMBA, NFT, ROAD, Ecosystem, Video game development, Cryptocurrency, Video game, Blockchain, Hackathon, Cosmos

ROAD TOWN, England, July 13, 2022 /PRNewswire/ -- Teams of game developers and individuals with passion for games will have a chance to win an initial prize of $5,000 and options to further develop their game with SmartML's support to join Kawaiiverse, the central hub for Anime and Manga creators in blockchain. The gaming ecosystem is just the beginning of this metaverse and opportunities are opening for more interested developers to join.

Key Points: 
  • Aiming to incubate the community-owned Anime Metaverse, Kawaiiverse recently launched their first ever Hackathon with the mission to find promising talents from all over the world, starting with gaming projects.
  • The gaming ecosystem is just the beginning of this metaverse and opportunities are opening for more interested developers to join.
  • Determined to expand the gaming ecosystem, one of the core lines of Kawaiiverse, the developer team is now holding the project's first ever hackathon.
  • Teams of independent developers and indie game studios, prepare your idea, set up the prototype and get ready to join Kawaiiverse.